Observing the Pharmaceutical Patents' Development and Portfolio of International Pharmaceutical Company by Patent Analysis - a Case Study of Anti-HER2 Targeted Drugs for Breast Cancer.
碩士 === 國立臺灣科技大學 === 專利研究所 === 103 === New drug research and innovation is a high-risk investment in the field of medicine, it has some characteristics, such as from R&D to launch a new drug to market is a time-consuming process and pharmaceutical companies still invest the great cost of capital...
Main Authors: | Ying-Hsiu Liu, 劉英秀 |
---|---|
Other Authors: | Chung-Huei Kuan |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/jf5ue7 |
Similar Items
-
Patents in the pharmaceutical industry
by: Jovanović Slobodanka
Published: (2003-01-01) -
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
Published: (2014) -
Patents and licensing in pharmaceutical industry
by: Katerina Ancevska Netkovska, et al.
Published: (2005-05-01) -
Utility requirement of Pharmaceutical Patents
by: Yu-hua Tsai, et al.
Published: (2015) -
Pharmaceutical patents retard pharmaceutical intervention and therapeutic intervention
by: Mannan, Adam James
Published: (2012)